Sirtex Medical Jobs

Sirtex Medical

WOBURN, MA | 1500 followers

Sirtex Medical Overview

WEBSITE sirtex.com
HEADQUARTERS WOBURN, MA
SIZE 1,000 - 3,000
FOUNDED 2004
CEO MARK KEVIN RICHARDSON
TYPE Private
REVENUE $50M - $200M
Related Companies
About Sirtex Medical

Sirtex develops and commercializes targeted radiation therapy for the treatment of liver cancer.

Create an Alert for Sirtex Medical Jobs
Create a Job Alert

Get notified when new Sirtex Medical jobs are posted

Email Address

Search Sirtex Medical Jobs

Sirtex Medical Jobs Near Me Remote Sirtex Medical Jobs Part-time Sirtex Medical Jobs

Browse Sirtex Medical Jobs ( View All Jobs )

Product Development Engineering Intern at Sirtex Medical

Woburn, MA | Intern
$89k-104k (estimate)
1 Month Ago
Sirtex Medical is a global leader in healthcare, with offices in the U.S., Australia, Germany, and Singapore, dedicated to improving patient outcomes. Our mission is to be at the forefront of minimally invasive cancer and embolization therapies. By partnering with physicians, we aim to provide innovative products that enhance patient outcomes and simplify treatments. Achieving this ambitious goal requires passionate and talented individuals who a...

Regional Sales Manager (Nationwide) at Sirtex Medical

Woburn, MA | Full Time
$119k-163k (estimate)
1 Month Ago
Company Description. Ready to be part of something bigger. Sirtex Medical is entering a new era of growth following the FDA approval of SIR-Spheres Y-90 resin microspheres for hepatocellular carcinoma (HCC). This breakthrough expands our impact in the fight against liver cancer and makes SIR-Spheres the first and only Y-90 radioembolization therapy in the U.S. approved to treat both HCC and metastatic colorectal cancer to the liver. It's a milest...

Regional Sales Manager (San Antonio) at Sirtex Medical

San Antonio, TX | Full Time
$114k-154k (estimate)
6 Months Ago
Company Description. Ready to be part of something bigger. Sirtex Medical is entering a new era of growth following the FDA approval of SIR-Spheres Y-90 resin microspheres for hepatocellular carcinoma (HCC). This breakthrough expands our impact in the fight against liver cancer and makes SIR-Spheres the first and only Y-90 radioembolization therapy in the U.S. approved to treat both HCC and metastatic colorectal cancer to the liver. It's a milest...
View All Jobs
Back